ANDA 73054, held by Purepac Pharm. Doxepin Hydrochloride.
As of Nov 16, 2026, ANDA 73054 (Doxepin Hydrochloride), held by Purepac Pharm, was first approved by FDA on Dec 28, 1990, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 28, 1990 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Doxepin HydrochlorideEQ 10MG BASE ยท capsule;oral | Doxepin Hydrochloride | Discontinued |
| Mar 26, 1991 | Supplement 1Labeling | Approved | None posted |
| Dec 28, 1990 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters